IOL Chemicals and Pharmaceuticals Limited (BOM: 524164)

Market Cap	28.43B
Revenue (ttm)	20.72B
Net Income (ttm)	1.19B
Shares Out	58.71M
EPS (ttm)	20.20
PE Ratio	23.98
Forward PE	14.72
Dividend	5.00 (1.04%)
Ex-Dividend Date	n/a

Volume	18,637
Open	484.30
Previous Close	479.70
Day's Range	477.95 - 496.75
52-Week Range	333.00 - 535.60
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 12, 2024

About IOL Chemicals and Pharmaceuticals

IOL Chemicals and Pharmaceuticals Limited manufactures and sells pharmaceutical and chemical products in India and internationally. The company offers active pharmaceutical ingredients (API), such as ibuprofen lysinate and ibuprofen sodium; and other APIs, including metformin, fenofibrate, lamotrigine, clopidogrel bisulphate, pantoprazole, gabapentin, levetiracetam, paracetamol, etc. Its active pharmaceutical ingredients are used for the treatment of anti-inflammatory, analgesic and antipyretic, anti-diabetic, anti- platelet, anti-cholesterol, ...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 1986
• Employees: 2,777
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 524164

Financial Performance

In 2023, IOL Chemicals and Pharmaceuticals's revenue was 21.33 billion, a decrease of -3.80% compared to the previous year's 22.17 billion. Earnings were 1.34 billion, a decrease of -3.39%.